Tag: registration

ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief Financial Officer, and Mr. Eric Huang, as Senior Vice President of Global Corporate Development and Finance. Both Dr. Misra and Mr. Huang will report directly to Dajun Yang, M.D., Ph.D., the Company’s Chairman & Chief Executive Officer.

PBKMiner is proud to announce a major innovation: the launch of an XRP-centric smart cloud mining contract. This contract allows users to easily mine XRP without specific hardware or experience and receive corresponding XRP rewards every day. This breakthrough development not only increases the participation opportunities for retail investors, but also significantly improves the accessibility of the entire XRP ecosystem.

ST. JOHN'S, Newfoundland and Labrador, July 07, 2025 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its second quarter 2025 financial results on Friday, August 1, 2025. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's second quarter financial results.

PARIS and CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’),  a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced two important developments that aim to reinforce the global positioning of potential first-in-class radioenhancer JNJ-1900 (NBTXR3), which is licensed by Janssen Pharmaceutica NV, a Johnson & Johnson company.

Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF

Supplementing the notice of 17^th June 2025 on convening the meeting of bondholders of UAB “Orkela” (code 304099538, registered address at Jogailos st. 4, Vilnius, Lithuania; the Company) bond issue, ISIN code LT0000405961 (the Bonds) on 9 January 2025 at 10 AM, Vilnius time¹ (the Meeting), the trustee of the bondholders UAB "AUDIFINA" (code 125921757, registered address at A. Juozapavičiaus st. 6, Vilnius, Lithuania; the Trustee), has the following additional information about the upcoming Meeting.